{"entity":{"type":"insider","cik":"0001561018","url":"/insider/0001561018","json_url":"/insider/0001561018.json","name":"Sabby Healthcare Master Fund, Ltd.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":10,"first":"2014-03-24","last":"2018-04-27","span_basis":"filed_date"},"name_variants":[{"name":"Sabby Healthcare Master Fund, Ltd.","source":"filing","n_filings":4,"first_seen":"2018-03-14","last_seen":"2018-04-27"},{"name":"Sabby Healthcare Volatility Master Fund, Ltd.","source":"filing","n_filings":6,"first_seen":"2014-03-24","last_seen":"2014-04-17"}],"transactions":[{"id":6888914,"accession":"0001535610-18-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001535610-18-000082","line_url":"/filing/0001535610-18-000082#line-1","is_derivative":false,"issuer_cik":"0001362959","issuer_name":"Rosetta Genomics Ltd.","issuer_ticker":"ROSG","issuer_name_source":null,"issuer_url":"/issuer/0001362959","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Sabby Healthcare Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"ADR Shares (each one equal to 2 ordinary shares)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7085.0,"shares_display":"7,085","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":2479.75,"total_display":"2,479.75","total_whole":"2,480","shares_owned_after":941693.0,"shares_owned_after_display":"941,693","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-26","filed_date":"2018-04-27","scope":"insider"},{"id":6504408,"accession":"0001535610-18-000070","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001535610-18-000070","line_url":"/filing/0001535610-18-000070","is_derivative":false,"issuer_cik":"0001362959","issuer_name":"Rosetta Genomics Ltd.","issuer_ticker":"ROSG","issuer_name_source":null,"issuer_url":"/issuer/0001362959","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Sabby Healthcare Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"ADR Shares (each one equal to 2 ordinary shares)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":64298.0,"shares_display":"64,298","price_per_share":0.4312457385921802,"price_display":"0.43","price_state":"stated","total_value":27728.2385,"total_display":"27,728.24","total_whole":"27,728","shares_owned_after":934599.0,"shares_owned_after_display":"934,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-16","filed_date":"2018-03-19","scope":"insider","n_lines":5},{"id":6597031,"accession":"0001535610-18-000069","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001535610-18-000069","line_url":"/filing/0001535610-18-000069","is_derivative":false,"issuer_cik":"0001362959","issuer_name":"Rosetta Genomics Ltd.","issuer_ticker":"ROSG","issuer_name_source":null,"issuer_url":"/issuer/0001362959","owner_cik":null,"owner_name":"Sabby Healthcare Master Fund, Ltd.; SABBY MANAGEMENT, LLC","owner_display_name":"Sabby Healthcare Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"ADR Shares (each one equal to 2 ordinary shares)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46570.0,"shares_display":"46,570","price_per_share":0.4203159222675542,"price_display":"0.42","price_state":"stated","total_value":19574.1125,"total_display":"19,574.11","total_whole":"19,574","shares_owned_after":838765.0,"shares_owned_after_display":"838,765","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-15","filed_date":"2018-03-16","scope":"insider","n_lines":5},{"id":6597020,"accession":"0001535610-18-000069","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001535610-18-000069","line_url":"/filing/0001535610-18-000069","is_derivative":false,"issuer_cik":"0001362959","issuer_name":"Rosetta Genomics Ltd.","issuer_ticker":"ROSG","issuer_name_source":null,"issuer_url":"/issuer/0001362959","owner_cik":null,"owner_name":"Sabby Healthcare Master Fund, Ltd.; SABBY MANAGEMENT, LLC","owner_display_name":"Sabby Healthcare Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"ADR Shares (each one equal to 2 ordinary shares)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73191.0,"shares_display":"73,191","price_per_share":0.421045511060103,"price_display":"0.42","price_state":"stated","total_value":30816.742,"total_display":"30,816.74","total_whole":"30,817","shares_owned_after":823740.0,"shares_owned_after_display":"823,740","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-14","filed_date":"2018-03-16","scope":"insider","n_lines":5},{"id":6166096,"accession":"0001535610-18-000068","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001535610-18-000068","line_url":"/filing/0001535610-18-000068","is_derivative":false,"issuer_cik":"0001362959","issuer_name":"Rosetta Genomics Ltd.","issuer_ticker":"ROSG","issuer_name_source":null,"issuer_url":"/issuer/0001362959","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Sabby Healthcare Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"ADR Shares (each one equal to 2 ordinary shares)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37319.0,"shares_display":"37,319","price_per_share":0.4202491224309333,"price_display":"0.42","price_state":"stated","total_value":15683.277,"total_display":"15,683.28","total_whole":"15,683","shares_owned_after":744220.0,"shares_owned_after_display":"744,220","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-14","scope":"insider","n_lines":2},{"id":6166091,"accession":"0001535610-18-000068","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001535610-18-000068","line_url":"/filing/0001535610-18-000068","is_derivative":false,"issuer_cik":"0001362959","issuer_name":"Rosetta Genomics Ltd.","issuer_ticker":"ROSG","issuer_name_source":null,"issuer_url":"/issuer/0001362959","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Sabby Healthcare Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"ADR Shares (each one equal to 2 ordinary shares)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":138509.0,"shares_display":"138,509","price_per_share":0.4163025723960176,"price_display":"0.42","price_state":"stated","total_value":57661.653,"total_display":"57,661.65","total_whole":"57,662","shares_owned_after":656073.0,"shares_owned_after_display":"656,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider","n_lines":10},{"id":6467846,"accession":"0001535610-14-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001535610-14-000056","line_url":"/filing/0001535610-14-000056#line-2","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Sabby Healthcare Volatility Master Fund, Ltd.; Mintz Hal","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17100.0,"shares_display":"17,100","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":85500.0,"total_display":"85,500.00","total_whole":"85,500","shares_owned_after":778030.0,"shares_owned_after_display":"778,030","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-15","filed_date":"2014-04-17","scope":"insider"},{"id":6467844,"accession":"0001535610-14-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001535610-14-000056","line_url":"/filing/0001535610-14-000056#line-1","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Sabby Healthcare Volatility Master Fund, Ltd.; Mintz Hal","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":5.21,"price_display":"5.21","price_state":"stated","total_value":15630.0,"total_display":"15,630.00","total_whole":"15,630","shares_owned_after":760930.0,"shares_owned_after_display":"760,930","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-14","filed_date":"2014-04-17","scope":"insider"},{"id":6659658,"accession":"0001535610-14-000055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001535610-14-000055","line_url":"/filing/0001535610-14-000055#line-3","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"Sabby Healthcare Volatility Master Fund, Ltd.; SABBY MANAGEMENT, LLC; Mintz Hal","owner_display_name":"Sabby Healthcare Volatility Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":515.0,"total_display":"515.00","total_whole":"515","shares_owned_after":757930.0,"shares_owned_after_display":"757,930","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-11","filed_date":"2014-04-11","scope":"insider"},{"id":6659654,"accession":"0001535610-14-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001535610-14-000055","line_url":"/filing/0001535610-14-000055#line-2","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"Sabby Healthcare Volatility Master Fund, Ltd.; SABBY MANAGEMENT, LLC; Mintz Hal","owner_display_name":"Sabby Healthcare Volatility Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":7350.0,"total_display":"7,350.00","total_whole":"7,350","shares_owned_after":757830.0,"shares_owned_after_display":"757,830","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-10","filed_date":"2014-04-11","scope":"insider"},{"id":6659651,"accession":"0001535610-14-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001535610-14-000055","line_url":"/filing/0001535610-14-000055#line-1","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"Sabby Healthcare Volatility Master Fund, Ltd.; SABBY MANAGEMENT, LLC; Mintz Hal","owner_display_name":"Sabby Healthcare Volatility Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1075.0,"shares_display":"1,075","price_per_share":5.51,"price_display":"5.51","price_state":"stated","total_value":5923.25,"total_display":"5,923.25","total_whole":"5,923","shares_owned_after":756430.0,"shares_owned_after_display":"756,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-09","filed_date":"2014-04-11","scope":"insider"},{"id":6589629,"accession":"0001535610-14-000054","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001535610-14-000054","line_url":"/filing/0001535610-14-000054#line-5","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Mintz Hal; Sabby Healthcare Volatility Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35500.0,"shares_display":"35,500","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":190280.0,"total_display":"190,280.00","total_whole":"190,280","shares_owned_after":755355.0,"shares_owned_after_display":"755,355","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-08","filed_date":"2014-04-08","scope":"insider"},{"id":6589627,"accession":"0001535610-14-000054","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001535610-14-000054","line_url":"/filing/0001535610-14-000054","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Mintz Hal; Sabby Healthcare Volatility Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20654.0,"shares_display":"20,654","price_per_share":5.705432361770117,"price_display":"5.71","price_state":"stated","total_value":117840.0,"total_display":"117,840.00","total_whole":"117,840","shares_owned_after":716101.0,"shares_owned_after_display":"716,101","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-07","filed_date":"2014-04-08","scope":"insider","n_lines":2},{"id":6589623,"accession":"0001535610-14-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001535610-14-000054","line_url":"/filing/0001535610-14-000054","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Mintz Hal; Sabby Healthcare Volatility Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12250.0,"shares_display":"12,250","price_per_share":6.073469387755102,"price_display":"6.07","price_state":"stated","total_value":74400.0,"total_display":"74,400.00","total_whole":"74,400","shares_owned_after":699201.0,"shares_owned_after_display":"699,201","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-04","filed_date":"2014-04-08","scope":"insider","n_lines":2},{"id":6387589,"accession":"0001535610-14-000052","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001535610-14-000052","line_url":"/filing/0001535610-14-000052#line-6","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"Sabby Healthcare Volatility Master Fund, Ltd.; Mintz Hal; SABBY MANAGEMENT, LLC","owner_display_name":"Sabby Healthcare Volatility Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":6.15,"price_display":"6.15","price_state":"stated","total_value":15375.0,"total_display":"15,375.00","total_whole":"15,375","shares_owned_after":686951.0,"shares_owned_after_display":"686,951","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-02","filed_date":"2014-04-02","scope":"insider"},{"id":6387587,"accession":"0001535610-14-000052","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001535610-14-000052","line_url":"/filing/0001535610-14-000052","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"Sabby Healthcare Volatility Master Fund, Ltd.; Mintz Hal; SABBY MANAGEMENT, LLC","owner_display_name":"Sabby Healthcare Volatility Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15371.0,"shares_display":"15,371","price_per_share":6.102759742371999,"price_display":"6.10","price_state":"stated","total_value":93805.52,"total_display":"93,805.52","total_whole":"93,806","shares_owned_after":684451.0,"shares_owned_after_display":"684,451","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-02","scope":"insider","n_lines":3},{"id":6387578,"accession":"0001535610-14-000052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001535610-14-000052","line_url":"/filing/0001535610-14-000052#line-2","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"Sabby Healthcare Volatility Master Fund, Ltd.; Mintz Hal; SABBY MANAGEMENT, LLC","owner_display_name":"Sabby Healthcare Volatility Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7936.0,"shares_display":"7,936","price_per_share":6.35,"price_display":"6.35","price_state":"stated","total_value":50393.6,"total_display":"50,393.60","total_whole":"50,394","shares_owned_after":669080.0,"shares_owned_after_display":"669,080","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-31","filed_date":"2014-04-02","scope":"insider"},{"id":6589620,"accession":"0001535610-14-000051","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001535610-14-000051","line_url":"/filing/0001535610-14-000051#line-4","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Mintz Hal; Sabby Healthcare Volatility Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":6.61,"price_display":"6.61","price_state":"stated","total_value":11237.0,"total_display":"11,237.00","total_whole":"11,237","shares_owned_after":658744.0,"shares_owned_after_display":"658,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-27","filed_date":"2014-03-27","scope":"insider"},{"id":6589618,"accession":"0001535610-14-000051","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001535610-14-000051","line_url":"/filing/0001535610-14-000051","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Mintz Hal; Sabby Healthcare Volatility Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14200.0,"shares_display":"14,200","price_per_share":6.663309859154929,"price_display":"6.66","price_state":"stated","total_value":94619.0,"total_display":"94,619.00","total_whole":"94,619","shares_owned_after":657044.0,"shares_owned_after_display":"657,044","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-26","filed_date":"2014-03-27","scope":"insider","n_lines":2},{"id":6589615,"accession":"0001535610-14-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001535610-14-000051","line_url":"/filing/0001535610-14-000051#line-1","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"SABBY MANAGEMENT, LLC; Mintz Hal; Sabby Healthcare Volatility Master Fund, Ltd.","owner_display_name":"SABBY MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":303.0,"shares_display":"303","price_per_share":6.9,"price_display":"6.90","price_state":"stated","total_value":2090.7,"total_display":"2,090.70","total_whole":"2,091","shares_owned_after":642844.0,"shares_owned_after_display":"642,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-25","filed_date":"2014-03-27","scope":"insider"},{"id":6327854,"accession":"0001535610-14-000050","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001535610-14-000050","line_url":"/filing/0001535610-14-000050#line-3","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"Sabby Healthcare Volatility Master Fund, Ltd.; Mintz Hal; SABBY MANAGEMENT, LLC","owner_display_name":"Sabby Healthcare Volatility Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2400.0,"shares_display":"2,400","price_per_share":6.71,"price_display":"6.71","price_state":"stated","total_value":16104.0,"total_display":"16,104.00","total_whole":"16,104","shares_owned_after":642541.0,"shares_owned_after_display":"642,541","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-24","filed_date":"2014-03-24","scope":"insider"},{"id":6327852,"accession":"0001535610-14-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001535610-14-000050","line_url":"/filing/0001535610-14-000050#line-2","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"Sabby Healthcare Volatility Master Fund, Ltd.; Mintz Hal; SABBY MANAGEMENT, LLC","owner_display_name":"Sabby Healthcare Volatility Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4900.0,"shares_display":"4,900","price_per_share":6.83,"price_display":"6.83","price_state":"stated","total_value":33467.0,"total_display":"33,467.00","total_whole":"33,467","shares_owned_after":640141.0,"shares_owned_after_display":"640,141","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-21","filed_date":"2014-03-24","scope":"insider"},{"id":6327849,"accession":"0001535610-14-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001535610-14-000050","line_url":"/filing/0001535610-14-000050#line-1","is_derivative":false,"issuer_cik":"0001433766","issuer_name":"Celsus Therapeutics Plc.","issuer_ticker":"CLTX","issuer_name_source":null,"issuer_url":"/issuer/0001433766","owner_cik":null,"owner_name":"Sabby Healthcare Volatility Master Fund, Ltd.; Mintz Hal; SABBY MANAGEMENT, LLC","owner_display_name":"Sabby Healthcare Volatility Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800.0,"shares_display":"3,800","price_per_share":6.9,"price_display":"6.90","price_state":"stated","total_value":26220.0,"total_display":"26,220.00","total_whole":"26,220","shares_owned_after":635241.0,"shares_owned_after_display":"635,241","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2014-03-24","scope":"insider"}],"collapsed":true,"next_cursor":"2014-03-20|6327849","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001362959","name":"Rosetta Genomics Ltd.","url":"/issuer/0001362959","role":"Ten percent owner","n_filings":4,"first_seen":"2018-03-14","last_seen":"2018-04-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001541157","name":"Celsus Therapeutics Plc.","url":"/issuer/0001541157","role":"Ten percent owner","n_filings":6,"first_seen":"2014-03-24","last_seen":"2014-04-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001561018","retrieved_at":"2026-08-26T04:32:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}